Sequent Scientific Limited has informed the Exchange about Schedule of meet
VIYASH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
SeQuent Scientific Limited has scheduled a conference call with analysts and investors on Wednesday, May 21, 2025, at 9:00 a.m. IST to discuss its Q4FY25 financial results. The call will be led by MD & CEO Rajaram Narayanan and CFO Saurav Bhala from SeQuent, along with Dr. Hari Babu Bodepudi (WTD & CEO) and Ramakant Singani (CFO) from Viyash Lifesciences, suggesting Viyash's results or combined figures will also be discussed. Dial-in numbers and a DiamondPass link for early registration have been shared with the exchanges. The disclosure is being made under SEBI's listing regulations, and the call details are also posted on the company's website.
This is a routine pre-earnings announcement and is unlikely to move the stock on its own. Investors should mark May 21 for the actual Q4FY25 numbers, which could trigger a price reaction depending on how results compare with market expectations.